GENETIC PREDICTORS OF DIABETIC FOOT SYNDROME DEVELOPMENT IN MEN AND WOMEN
https://doi.org/10.52485/19986173_2021_3_1
Abstract
Purpose of the study. Analysis of the frequency of occurrence of polymorphisms C786T of the eNOS gene, Lys198Asn of the END1 gene, T1565C (Leu33Pro) of the ITGB3 gene, G1691A of the F5 gene, G20210A of the F2 gene, A8202G of the MMP9 gene, A1298C of the MTHFR gene, C634G of the VEGFA gene in women with diabetes.
Materials and methods. The polymerase chain reaction method was used to study gene polymorphisms in 72 men and 127 women with diabetic feet and 73 men and 125 women with uncomplicated diabetes mellitus. Analysis of the results included Hardy-Weinberg law compliance, Pearson's chi-square, odds ratio, and its confidence interval.
Results: In men with diabetes mellitus and diabetic foot, differences were found between the frequency of occurrence of variants of the A8202G polymorphism of the MMP9 gene. The A/G genotype was found 1.8 times more often in diabetes mellitus. The frequency of the G/G genotype in diabetic foot is 1.6 times higher. With this genotype, the risk of developing a diabetic foot doubles. In women with diabetic feet, the A/A genotype of the A1298C polymorphism of the MTHFR gene was 1.2 times more frequent. The A/C genotype in women with diabetes was found 1.5 times more often. The C/C genotype in diabetic feet was 1.4 times more common.In the presence of the A/C genotype in women, the risk of developing diabetic foot syndrome is reduced by 50%.
Conclusion. The G/G genotype of the A8202G polymorphism of the MMP9 gene in men predisposes to the development of diabetic foot. The C/C genotype of the A1298C polymorphism of the MTHFR gene in women is associated with a protective effect on the development of diabetic foot.
About the Authors
N. I. TroitskayaRussian Federation
39a Gorky str., Chita,672000
K. G. Shapovalov
Russian Federation
39a Gorky str., Chita,672000
V. A. Mudrov
Russian Federation
39a Gorky str., Chita,672000
References
1. International Diabetes Federation. IDF Diabetes Atlas. Belgium: International Diabetes Federation; 2017. https://diabetesatlas.org/resources/2017-atlas.html.
2. Standards of Medical Care in Diabetes-2017: Summary of Revisions. Diabetes Care. 2017. 40(Suppl 1). S4-S5. doi: 10.2337/dc17-S003.
3. Koreyba K.A., Minabutdinov A.R., Tueshev L.M., Nuretdinov A.R., Lukin P.S. Diabetic foot syndrome. Inpatient replacement technique based on FASTTRACK-surgery. Statsionarozameshchayushchie tekhnologii: ambulatornayak hirurgiya. 2019. 1-2. 72 – 79.
4. Zheng Y., Ley S.H., Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018. 14(2). 88-98. doi: 10.1038/nrendo.2017.151.
5. Glovaci D., Fan W., Wong N.D. Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Curr. Cardiol. Rep. 2019. 21(4). 21. doi: 10.1007/s11886-019-1107-y. PMID: 30828746.
6. Dubrovshchik O.I., Garelik P.V., Dovnar I.S., RakovichD.Yu., Sytyy A.A. Real possibilities of reducing the frequency of lower limb amputations in patients with purulent-necrotic complications of diabetic foot syndrome. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta. 2015. 4 (52). 26 - 29.
7. Kurlaev P.P., Gritsenko V.A., BelozertsevaYu.P. Modern approaches to antibacterial therapy of purulent-necrotic complications of diabetic foot syndrome. Byulleten' Orenburgskogo nauchnogo tsentra Ural'skogo otdeleniya Rossiyskoy akademii nauk. 2016. 2. 1 - 13.
8. Belushkina N.N., Chemezov A.S., Pal'tsev M.A. Genetic research of multifactorial diseases in the concept of personalized medicine. Profilakticheskaya meditsina. 2019. 3. 26 – 30.
9. Dedov I.I., Shestakova M.V., Mayorov A.Yu., Vikulova O.K., Galstyan G.R., Kuraeva T.L., Peterkova V.A., Smirnova O.M., Starostika E.G., Surkova E.V., Sukhareva O.Yu., Tokmakova A.Yu., Shamkhalova M.Sh., Yarek-Martynova I.R., Beshlieva D.D., Bondarenko O.N., Volevodz N.N., Grigoryan O.R., Esayan R.M., Ibragimova L.I., Kalashnikov V.Yu., Lipatov D.V., Shestakova E.A. Algorithms for specialized medical care for patients with diabetes mellitus. Sakharnyy diabet. 2017. 1S. 1 – 121. DOI: 10.14341/DM20171S8.
10. Kamynina L.L., Chernus' N.P. Management of type 2 diabetes mellitus: the impact of urbanization. Zdorov'e megapolisa. 2020. № 2. 76-88.
11. Tsygankova O.V., Badin A.R., Bondareva Z.G., Lozhkina N.G., Platonov D.Yu. Associations of sex hormones with components of insulin-glucose homeostasis. Ozhirenie i metabolizm. 2018. 15(2). 3-10. https://doi.org/10.14341/omet9482.
12. Bekaert M., Van Nieuwenhove Y., Calders P., et al. Determinants of testosterone levels in human male obesity. Endocrine. 2015; 50(1): 202-211. doi: 10.1007/s12020-015-0563-4.
Review
For citations:
Troitskaya N.I., Shapovalov K.G., Mudrov V.A. GENETIC PREDICTORS OF DIABETIC FOOT SYNDROME DEVELOPMENT IN MEN AND WOMEN. Transbaikalian Medical Bulletin. 2021;(3):1-7. (In Russ.) https://doi.org/10.52485/19986173_2021_3_1